Related Experiment Video
Updated: May 12, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Development and application of machine learning models for hematological disease diagnosis using routine laboratory
Jingya Liu1,2,3, Yang Gou1,2,3, Wuchen Yang1,2,3
1Medical Center of Hematology, The Second Affiliated Hospital of Army Medical University, Chongqing, China.
Machine learning models accurately diagnose hematological diseases using clinical parameters. These models, especially the simplified ensemble model, offer efficient screening, improving patient outcomes and accessibility in healthcare.
Area of Science:
- Hematology
- Machine Learning
- Medical Diagnostics
Background:
- Hematological diseases are increasing, necessitating early and accurate diagnosis for improved patient prognosis.
- Traditional diagnostic methods can be time-consuming and resource-intensive.
Purpose of the Study:
- To develop and evaluate machine learning models for the early diagnosis of hematological diseases.
- To compare the performance of these models against human hematologists.
- To create a user-friendly diagnostic platform.
Main Methods:
- Utilized 54 clinical and laboratory parameters to train 7 machine learning models.
- Employed feature selection and ensemble methods to optimize model performance.
- Interpreted model decisions using SHapley Additive exPlanations (SHAP).
Main Results:
- Two ensemble models, EnMod1-46 (46 features) and EnMod2-12 (12 features), showed high accuracy (up to 0.804) and AUC (up to 0.964) in diagnosing 16 hematological diseases.
- SHAP analysis identified key parameters like Platelets (PLT), White Blood Cell (WBC) count, Mean Corpuscular Volume (MCV), Hemoglobin (HGB), Red Blood Cell (RBC) count, and age.
- Models outperformed junior hematologists and matched senior hematologists, with a user-friendly platform developed based on the simplified model.
Conclusions:
- Developed accurate and efficient machine learning models for hematological disease screening.
- The simplified model (EnMod2-12) offers a practical solution, especially for resource-limited settings.
- The diagnostic platform enhances accessibility and risk assessment for hematological conditions.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020